A Genome-Wide Association Study in Early COPD: Identification of One Major Susceptibility Loci

References

• AdeloyeD, ChuaS, LeeC, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2). doi:10.7189/jogh.05.020415.
   Web of Science ®Google Scholar
• LopezA, ShibuyaK, RaoC, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. doi:10.1183/09031936.06.0002580516452599
   PubMed Web of Science ®Google Scholar
• BascomR. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenet Genomics. 1991;1(2):102–106. doi:10.1097/00008571-199111000-00008
   Web of Science ®Google Scholar
• ManninoDM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5):121S–126S. doi:10.1378/chest.121.5_suppl.121S12010839
   PubMed Web of Science ®Google Scholar
• ManninoDM. Chronic obstructive pulmonary disease: definition and epidemiology. Respir Care. 2003;48(12):1185–1193.14651759
   PubMedGoogle Scholar
• SilvermanEK, SandhausRA. Alpha1-antitrypsin deficiency. N Engl J Med. 2009;360(26):2749–2757. doi:10.1056/NEJMcp090044919553648
   PubMed Web of Science ®Google Scholar
• PillaiSG, GeD, ZhuG, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet. 2009;5(3):e1000421. doi:10.1371/journal.pgen.100042119300482
   PubMed Web of Science ®Google Scholar
• ChoMH, BoutaouiN, KlandermanBJ, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010;42(3):200. doi:10.1038/ng.53520173748
   PubMed Web of Science ®Google Scholar
• HobbsBD, ParkerMM, ChenH, et al. Exome array analysis identifies a common variant in IL27 associated with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;194(1):48–57. doi:10.1164/rccm.201510-2053OC26771213
   PubMed Web of Science ®Google Scholar
• FerhaniN, LetuveS, KozhichA, et al. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(9):917–927. doi:10.1164/rccm.200903-0340OC20133931
   PubMed Web of Science ®Google Scholar
• General USJWDoH, Services H. The Health Benefits of Smoking Cessation. Washington: Department of Health and Human Services; 1990.
   Google Scholar
• SorianoJB, PolverinoF, CosioB. What is early COPD and why is it important? Eur Respir J. 2018;52(6):1801448. doi:10.1183/13993003.01448-201830309976
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.76637927663792
   PubMed Web of Science ®Google Scholar
• MaranetraN, ChandanayingyongD, BoYornklttlS. HLA antigen and ventilatory drive in Thais with chronic obstructive pulmonary disease. Asian Paci J Allerg Immunol. 1990;8(2):137.
   PubMed Web of Science ®Google Scholar
• FanerR, CruzT, AgustiA. Immune response in chronic obstructive pulmonary disease. Expert Rev Clin Immunol. 2013;9(9):821–833. doi:10.1586/1744666X.2013.82887524070046
   PubMed Web of Science ®Google Scholar
• QiuW, ChoMH, RileyJH, et al. Genetics of sputum gene expression in chronic obstructive pulmonary disease. PLoS One. 2011;6(9):e24395. doi:10.1371/journal.pone.002439521949713
   PubMed Web of Science ®Google Scholar
• HardinM, ChoM, McDonaldM-L, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;erj02160–02013.
   Google Scholar
• QianY, MaoZ-D, ShiY-J, LiuZ-G, CaoQ, ZhangQ. Comprehensive analysis of miRNA-mRNA-lncRNA networks in non-smoking and smoking patients with chronic obstructive pulmonary disease. Cell Physiol Biochem. 2018;50(3):1140–1153. doi:10.1159/00049454130355907
   PubMedGoogle Scholar
• DhitalR, BasnetS, PaudelP, AcharyaYP, PoudelDR. Prevalence of chronic obstructive pulmonary disease (COPD) among rheumatoid arthritis: results from national inpatient database. J Commun Hosp Internal Med Perspect. 2018;8(4):211–214. doi:10.1080/20009666.2018.1485460
   PubMed Web of Science ®Google Scholar
• KleinJ, SatoA, MackayIR, RosenFS. The HLA system. N Engl J Med. 2000;343(10):702–709. doi:10.1056/NEJM20000907343100610974135
   PubMed Web of Science ®Google Scholar
• PearsonG, RobinsonF, Beers GibsonT, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153–183.11294822
   PubMed Web of Science ®Google Scholar
• KlingerS, TurgeonB, LévesqueK, WoodGA, Aagaard-TilleryKM, MelocheS. Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality. Proc Natl Acad Sci. 2009;106(39):16710–16715. doi:10.1073/pnas.090091910619805361
   PubMed Web of Science ®Google Scholar
• PewBK, HarrisRA, SbranaE, et al. Structural and transcriptomic response to antenatal corticosteroids in an Erk3-null mouse model of respiratory distress. Am J Obstet Gynecol. 2016;215(3):384.e381–384. e389. doi:10.1016/j.ajog.2016.04.043
   PubMed Web of Science ®Google Scholar
• GuamanMC, SbranaE, ShopeC, et al. Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome–associated neonatal lethality in Erk3−/− mouse pups. Pediatr Res. 2014;76(1):24. doi:10.1038/pr.2014.5424732107
   PubMed Web of Science ®Google Scholar
• ChenG, CoureyAJ. Groucho/TLE family proteins and transcriptional repression. Gene. 2000;249(1–2):1–16. doi:10.1016/S0378-1119(00)00161-X10831834
   PubMed Web of Science ®Google Scholar
• JenningsBH, Ish-HorowiczD. The Groucho/TLE/Grg family of transcriptional co-repressors. Genome Biol. 2008;9(1):205. doi:10.1186/gb-2008-9-1-20518254933
   PubMed Web of Science ®Google Scholar
• TerryJ, SaitoT, SubramanianS, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007;31(2):240–246. doi:10.1097/01.pas.0000213330.71745.3917255769
   PubMed Web of Science ®Google Scholar
• KnöselT, HeretschS, Altendorf-HofmannA, et al. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t (X; 18): analysis of 319 cases. Eur J Cancer. 2010;46(6):1170–1176. doi:10.1016/j.ejca.2010.01.03220189377
   PubMed Web of Science ®Google Scholar
• YaoX, IrelandSK, PhamT, et al. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin. Biochem Biophys Res Commun. 2014;455(3):277–284. doi:10.1016/j.bbrc.2014.11.00725446087
   PubMed Web of Science ®Google Scholar
• RamasamyS, SaezB, MukhopadhyayS, et al. Tle1 tumor suppressor negatively regulates inflammation in vivo and modulates NF-κB inflammatory pathway. Proc Natl Acad Sci. 2016;113(7):1871–1876. doi:10.1073/pnas.151138011326831087
   PubMed Web of Science ®Google Scholar
• ZhongN, WangC, YaoW, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760.17575095
   PubMed Web of Science ®Google Scholar
• ZhouY, ZhongN-S, LiX, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017;377(10):923–935. doi:10.1056/NEJMoa170022828877027
   PubMed Web of Science ®Google Scholar
• WelteT, VogelmeierC, PapiA. COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract. 2015;69(3):336–349. doi:10.1111/ijcp.1252225363328
   PubMed Web of Science ®Google Scholar
• HwangYI, ParkYB, YooKH. Recent trends in the prevalence of chronic obstructive pulmonary disease in Korea. Tuberc Respir Dis (Seoul). 2017;80(3):226–229. doi:10.4046/trd.2017.80.3.22628747954
   PubMed Web of Science ®Google Scholar